Drug Type Non-recombinant coagulation factor |
Synonyms- |
Action modulators |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Blood Coagulation Disorders | NDA/BLA | China | 29 Apr 2022 | |
| Hemophilia B | Phase 3 | China | 13 Dec 2024 | |
| Acquired coagulation factor deficiency | IND Approval | China | 29 Aug 2024 |






